Back
Corporate News
Alivus Life Sciences’ board approved allotment of shares to employees exercising stock options
30-Jul-2026, 09:34
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) announced that its board of directors approved the allotment of 32,000 equity shares of Rs 2 face value each to eligible employees who exercised stock options under the ‘Employee Stock Option Scheme, 2021’, increasing the company's paid-up share capital from 12,27,39,448 equity shares aggregating to Rs 24,54,78,896 to 12,27,71,448 equity shares aggregating to Rs 24,55,42,896.
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) announced that its board of directors approved the allotment of 32,000 equity shares of Rs 2 face value each to eligible employees who exercised stock options under the ‘Employee Stock Option Scheme, 2021’, increasing the company's paid-up share capital from 12,27,39,448 equity shares aggregating to Rs 24,54,78,896 to 12,27,71,448 equity shares aggregating to Rs 24,55,42,896.